Designing Ethical Trials of Germline Gene Editing

Published on Nov 16, 2017in The New England Journal of Medicine70.67
· DOI :10.1056/NEJMp1711000
Bryan Cwik2
Estimated H-index: 2
(PSU: Portland State University)
With gene-editing technology advancing rapidly, it is important to consider the ethical issues it raises for research, including those related to intergenerational monitoring — long-term follow-up monitoring of not just trial participants, but also their descendants.
  • References (2)
  • Citations (5)
#1Hong Ma (Oregon National Primate Research Center)H-Index: 27
#2Nuria Marti-Gutierrez (OHSU: Oregon Health & Science University)H-Index: 1
Last.Riffat Ahmed (OHSU: Oregon Health & Science University)H-Index: 10
view all 31 authors...
#1Theodore Friedmann (UCSD: University of California, San Diego)H-Index: 49
#2Erica C. Jonlin (UW: University of Washington)H-Index: 6
Last.Michel Sadelain (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 70
view all 7 authors...
Cited By5
#1Erika Kleiderman (McGill University)H-Index: 5
#2Vardit Ravitsky (UdeM: Université de Montréal)H-Index: 14
Last.Bartha Maria Knoppers (McGill University)H-Index: 49
view all 3 authors...
#1Meow-Keong Thong (UM: University of Malaya)H-Index: 17
#2Yiling See-Toh (UM: University of Malaya)H-Index: 1
Last.Jaffar Syed Mohamed Ali (IIUM: International Islamic University Malaysia)H-Index: 2
view all 4 authors...
View next paperCRISPR/Cas9-mediated gene editing in human tripronuclear zygotes